Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 October 2022 | Story NONSINDISO QWABE | Photo Rio Button
The Lowveld serotine bat, named Neoromicia hlandzeni
The Lowveld serotine bat, named Neoromicia hlandzeni.

Biological expeditions to the unexplored central highlands of Angola between 2016 and 2019 led to the discovery of a new tiny, white-thumbed bat species from Eswatini by Prof Peter John Taylor from the UFS Department of Zoology and Entomology and the Afromontane Research Unit (ARU), together with colleagues from the University of Eswatini (UNESWA) and other collaborators.

The bat species, named Neoromicia hlandzeni or the Lowveld serotine bat – after the Lowveld of Eswatini (eHlandzeni) – is the first new animal species to be discovered in Eswatini and given a siSwati name. The Lowveld serotine bat is tiny at four grams, has a distinctive white thumb pad, and occurs in Eswatini, South Africa, Zimbabwe, and Mozambique.

Bats make up a quarter of all mammalian biodiversity. With modern technology and the exploration of previously inaccessible regions of Africa, the rate of discovery of both animal and plant species is accelerating.

According to Prof Taylor, the Lowveld serotine bat is a new species to science. The specimen from which the species was named was collected in the lowlands of Eswatini in 2005. “Later collections of bats from the highlands of Angola, undertaken by myself and students, revealed the fact that the highland and lowland forms were actually different species. Since there was already a name for the highland bat, we needed to find a new name for the lowland bat from Eswatini and South Africa, hence it is called the Lowveld serotine bat,” he said.

The importance of integrative taxonomy, local collaboration, and biodiversity surveys

Prof Taylor is a research fellow of the National Geographic Okavango Wilderness Project, and the bat discovery took place during expeditions under the patronage of the Angolan government, the Wild Bird Trust, and the National Geographic Okavango Wilderness Project. He said the aim of the expedition was to explore the plants and animals of a wilderness area (the source of the Okavango) that had not been explored before.

The discovery also led to their paper being published in the scientific journal, the Zoological Journal of the Linnean Society, this month. 

The publication, titled Integrative taxonomic analysis of new collections from the central Angolan highlands resolves the taxonomy of African pipistrelloid bats on a continental scale, showcases the importance of integrative taxonomy, local collaboration, and biodiversity surveys, as the description of this exciting new species would not have been possible without comparative genetic and morphological material from new collections in the poorly sampled central highlands of Angola. 
Prof Peter Taylor with his students, Veli Mdluli and Alexandra Howard
Prof Peter Taylor with his students, Veli Mdluli and Alexandra Howard, working on bat research. Howard was one of the co-authors of the paper. (Photo: Supplied)

Afromontane regions as hotspots of bat speciation, diversity, and micro-endemism

Although Prof Taylor is the first author to describe this new species, the work was done with a multidisciplinary team of colleagues, students, and collaborators from the UFS, UNESWA, the University of Pretoria, the University of Venda, and Stellenbosch University, as well as the Durban Natural Science Museum and the Ditsong National Museum of Natural History, with support from the Angolan government, the Wild Bird Trust, and the National Geographic Okavango Wilderness Project. 
“Describing a new species is an arduous task that can take years from discovery to publication. All the enormous collective efforts have shown the importance of collaborative biodiversity exploration using old and modern technologies, as well as the African ownership of this discovery,” Prof Taylor said.

Three of Prof Taylor's previous and current PhD students – all of them South African women – were part of this discovery process and are co-authors of the paper. All 14 co-authors in the team are African. Prof Taylor said the discovery adds a new species to the total bat list of 125 species for Southern Africa – at number 126.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept